awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37195567-67139D06-2E01-4858-98BA-ADF47E85D448
Q37195567-67139D06-2E01-4858-98BA-ADF47E85D448
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37195567-67139D06-2E01-4858-98BA-ADF47E85D448
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection:
P2860
Q37195567-67139D06-2E01-4858-98BA-ADF47E85D448
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37195567-67139D06-2E01-4858-98BA-ADF47E85D448
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e0221b0b38fb9e98f7651de6540de4f42b3fdfab
P2860
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation.